A Monocentric, Prospective, Longitudinal and Observational Natural History Study for Patients With Angelman Syndrome in CHR Citadelle Liège : NatHis-Angelman

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

This study is a 9-year natural history study for patients with Angelman syndrome in Belgium (a genetic neurodevelopmental disorder, affecting 500,000 individuals in the world). It includes a 3-year recruitment phase, a 5 year follow-up and a year to analyze the collected data. The investigators plan to include 30 patients with a semi-annual follow-up for 4 years. The investigators will collect relevant retrospective and prospective data using age-standardized scales and questionnaires for functional motor assessments and global developmental assessment.

Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:

• Genetically confirmed diagnosis of AS

• 0-99 years

• Male or Female

• Participant's carer is willing to give IC/sign a record of consultation for participation in the study

Locations
Other Locations
Belgium
CHR Citadelle Liège
RECRUITING
Liège
Contact Information
Primary
Noor Benmhammed
Noor.Benmhammed@citadelle.be
43217726
Backup
Tamara Dangouloff, PhD
tamara.dangouloff@uliege.be
Time Frame
Start Date: 2021-10-10
Estimated Completion Date: 2028-01
Participants
Target number of participants: 30
Related Therapeutic Areas
Sponsors
Leads: Centre Hospitalier Universitaire de Liege
Collaborators: SYSNAV, Centre Hospitalier Régional de la Citadelle

This content was sourced from clinicaltrials.gov